Company profile: SQZ Biotech
1.1 - Company Overview
Company description
- Provider of cell engineering technology designed to deliver a diverse set of materials into patient cells and to develop cellular therapies for multiple indications using proprietary CellSqueeze technology, advanced through internal research programs and external partnerships.
Products and services
- Cellular Therapy Development Programs: SQZ architects multi-indication cellular therapy products using its CellSqueeze technology to deliver diverse materials into patient cells through its cell engineering approach
- Cell Squeeze® Technology: SQZ engineers a proprietary cell engineering technology that delivers a diverse set of materials into patient cells, supporting development of cellular therapies across multiple indications
- External Partnership Programs: SQZ offers research-driven partnerships applying CellSqueeze technology to deliver diverse materials into patient cells, complementing internal research programs for cellular therapy development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SQZ Biotech
Breath Therapeutics
HQ: Germany
Website
- Description: Provider of inhaled investigational therapies for rare respiratory diseases, combining novel formulations of existing drugs with cutting-edge inhalation technology. Pipeline includes Liposomal Cyclosporine A for Inhalation for bronchiolitis obliterans syndrome to deliver drug to lungs while minimizing systemic exposure, and inhaled colistimethate sodium for non-cystic fibrosis bronchiectasis targeting Pseudomonas aeruginosa.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Breath Therapeutics company profile →
ChemoMetec
HQ: Denmark
Website
- Description: Provider of user-friendly instruments and software for precise cell counting and viability, including NucleoCounter NC-202 and NC-200 automated cell counters, XcytoMatic 40 for cell density analysis, Via2-Cassette disposable sampling cassettes, and NC-View/NucleoView image-analysis software, serving production/R&D, GMP, quality control, clinical diagnostics, cell therapy, and large pharmaceutical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemoMetec company profile →
Microchips Biotech
HQ: United States
Website
- Description: Provider of a proprietary microchip-based implant for long-term, precise drug delivery. The subcutaneous device stores and releases exact doses over months and years and is placed under the skin by a trained physician in a simple office procedure using local anesthesia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microchips Biotech company profile →
Viventis Microscopy
HQ: Switzerland
Website
- Description: Provider of novel light sheet microscopy systems, including the Viventis LS2 Live light sheet fluorescence microscope with multi-view and multi-position imaging for detailed visualization of biological samples over time.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viventis Microscopy company profile →
Cytena
HQ: Germany
Website
- Description: Provider of single-cell printing and isolation technologies for cell research and professional diagnostics, offering the cy-Clone device to separate single cells for biologics development and genetic analysis in cancer and stem cell research, and instruments including UP.SIGHT, C.SIGHT 2.0, B.SIGHT, CELLCYTE X, C.WASH PLUS, and the C.LIVE Caspase-3 Green NucView assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytena company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SQZ Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SQZ Biotech
2.2 - Growth funds investing in similar companies to SQZ Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SQZ Biotech
4.2 - Public trading comparable groups for SQZ Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →